Instituto Botânio

Botanio is a Brazilian biotechnology company and research institute specializing in the therapeutic application of cannabinoids and other plant-derived compounds. The organization focuses on bridging the gap between scientific research and clinical practice through medical education, R&D, and patient access programs. Botanio develops standardized phytotherapeutic formulations targeting the endocannabinoid system to treat conditions such as refractory epilepsy, chronic pain, and neurodegenerative diseases. Based in Brazil, the company plays a pivotal role in the country's emerging medical cannabis market by providing technical expertise and high-quality medicinal products. Their business model integrates product development with a robust educational platform for healthcare professionals.